Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Phase 3 Study Update of Tivozanib for First-Line Advanced Renal Cell Carcinoma - Monthly Prescribing Reference |
 |
 |
|
Monthly Prescribing Reference AVEO and Astellas announced detailed data from TIVO-1 (Tivozanib Versus Sorafenib in 1 st line Advanced Renal Cell Carcionma [RCC]). TIVO-1 was a global, randomized Phase 3 superiority clinical trial evaluating the efficacy and safety of ... Astellas & AVEO: Tivozanib Successfully Demonstrates the Longest Reported ... MarketWatch (press release) Aveo sees positive safety data for kidney cancer drug Mass High Tech Aveo, Astellas Report Positive Data from Phase III Comparative Tivozanib Trial |
